文献速递妇科生殖医学

白细胞介素-6反式信号通路持续激活信号转导及转录激活因子3参与子宫内膜异位症纤维化

Persistent activation of signal transducer and activator of transcription 3 via interleukin-6 trans-signaling is involved in fibrosis of endometriosis.
PubMed 文献 · Hum Reprod · 2022-01-01

本研究分析60例深部子宫内膜异位症患者的内膜和/或内异症样本及32例健康育龄妇女子宫内膜样本,探讨Toll样受体配体、IL-6/sIL-6R/STAT3信号对子宫内膜异位症基质细胞促纤维化表型的影响。结果显示IL-6反式信号通路持续激活STAT3参与子宫内膜异位症纤维化,敲低STAT3或药物抑制STAT3可减轻促纤维化表型。

要点

  • 子宫内膜异位症基质细胞中Toll样受体配体预刺激4小时后再刺激可显著增加IL-6分泌。
  • IL-6/sIL-6R可诱导子宫内膜异位症基质细胞促纤维化表型及NF-κB激活。
  • 敲低STAT3或S3I-201可减轻IL-6/sIL-6R诱导的促纤维化表型及NF-κB激活。

核心结论

  • 通过IL-6反式信号通路持续激活STAT3参与子宫内膜异位症纤维化。

研究设计与样本

  • 分析60例有组织学证据的深部子宫内膜异位症患者的内膜和/或内异症样本及32例健康育龄妇女子宫内膜样本。
  • 体外研究Toll样受体2、3、4配体预刺激对子宫内膜及内异症基质细胞炎症介质分泌的影响。
  • 体外研究IL-6/sIL-6R/STAT3信号及敲低STAT3或S3I-201对促纤维化表型的影响。

主要发现

  • 健康妇女子宫内膜基质细胞预刺激24小时显著降低二次刺激后IL-6分泌,预刺激4小时无显著影响。
  • 子宫内膜异位症基质细胞预刺激4小时显著增加二次刺激后IL-6分泌,预刺激24小时无显著影响。
  • IL-6/sIL-6R诱导子宫内膜异位症基质细胞促纤维化表型及NF-κB激活,对健康妇女子宫内膜基质细胞无显著影响。
  • TGF-β1和/或IL-6/sIL-6R刺激1小时和48小时激活子宫内膜异位症基质细胞STAT3,但SOCS1和SOCS3蛋白表达极低或无。
  • 健康妇女子宫内膜基质细胞IL-6/sIL-6R刺激1小时诱导STAT3和SOCS1/3表达,48小时未检测到STAT3激活。

临床怎么用

  • 作者认为IL-6/sIL-6R/STAT3信号负调控因子功能障碍可能导致子宫内膜异位症中STAT3持续激活。
  • 作者指出STAT3激活对胚胎成功着床至关重要,因此STAT3抑制剂治疗不适合希望怀孕的女性。
  • 作者认为靶向IL-6/sIL-6R/STAT3信号受损的负调控可能仍是治疗子宫内膜异位症的有前景途径。

局限性

  • 需要体内研究来确认目前的体外结果。
  • 在动物模型中模拟非消退性慢性炎症仍然具有挑战性,因为活动性炎症可自行消退。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is activation of signal transducer and activator of transcription 3 (STAT3) via interleukin-6 (IL-6) trans-signaling involved in fibrosis of endometriosis? SUMMARY ANSWER: Persistent activation of STAT3 via IL-6 trans-signaling is involved in fibrosis of endometriosis. WHAT IS KNOWN ALREADY: Our previous study showed that sustained low-grade inflammation promotes a fibrotic phenotype in endometriotic stromal cells. However, the underlying mechanisms of the establishment of non-resolving, low-grade inflammation in endometriosis remain to be clarified. STUDY DESIGN, SIZE, DURATION: Endometrial and/or endometriotic samples of 60 patients who had histological evidence of deep endometriosis and endometrial samples from 32 healthy fertile women were analyzed. PARTICIPANTS/MATERIALS, SETTING, METHODS: The effects of priming with ligands of Toll-like receptors (TLRs) 2, 3 and 4 on secretion of inflammatory mediators (tumor necrosis factor-α, C-X-C motif chemokine ligand-10 [CXCL-10], IL6 and IL-10) after a second challenge with TLR ligands in endometrial and endometriotic stromal cells were investigated. Then, the effects of IL-6/soluble (s) IL-6 receptor (R)/STAT3 signaling, as well as inhibition of STAT3 activation by knockdown of STAT3 or pharmacological inhibition (S3I-201), on the pro-fibrotic phenotype in endometrial and endometriotic stromal cells in vitro were investigated. MAIN RESULTS AND THE ROLE OF CHANCE: Priming with TLR ligands for 4 h had no significant effects, whereas 24 h of priming significantly decreased secretion of IL-6, after a second challenge in endometrial stromal cells of healthy women. In endometriotic stromal cells, whereas 24 h of priming had no significant effects, priming with TLR ligands for 4 h significantly increased secretion of IL-6 after a second challenge. IL-6/soluble IL-6 receptor (sIL-6R) induced a pro-fibrotic phenotype (cell proliferation, collagen type I synthesis, α-smooth muscle actin positive stress fibers, cell migration and collagen gel contraction) as well as nuclear factor-kappa B (NF-κB) activation of endometriotic stromal cells. In contrast, IL-6/sIL-6R had no significant effects on either a pro-fibrotic phenotype or NF-κB activation of endometrial stromal cells of healthy women. Stimulation with transforming growth factor (TGF)-β1 and/or IL-6/sIL-6R for 1 h and 48 h activated STAT3, but induced very low or no suppressor of cytokine signaling (SOCS) 1 and 3 protein expression in endometriotic stromal cells. In endometrial stromal cells of healthy women, IL-6/sIL-6R-induced STAT3 and SOCS1/3 expression at 1 h, whereas no STAT3 activation was detected at 48 h. Knockdown of STAT3 gene or S3I-201 (a STAT3 inhibitor) decreased the IL-6/sIL-6R-induced pro-fibrotic phenotype as well as NF-κB activation and TGF-β1-induced cell proliferation of endometriotic stromal cells. LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: In vivo studies are required to confirm the present in vitro results. However, it remains challenging to mimic non-resolving chronic inflammation in animal models, as active inflammation can resolve spontaneously. WIDER IMPLICATIONS OF THE FINDINGS: Dysfunction of negative regulators of IL-6/sIL-6R/STAT3 signaling may cause persistent activation of STAT3 in endometriosis. Since STAT3 activation in the endometrium is essential for successful embryo implantation, treatment with STAT3 inhibitors would not be appropriate for women wishing to conceive. However, targeting impaired negative regulation of IL-6/sIL-6R/STAT3 signaling may still represent a promising avenue for the treatment of endometriosis. STUDY FUNDING/COMPETING INTEREST(S): This study was supported in part by the KARL STORZ SE & Co. KG (Tuttlingen, Germany). There are no conflicts of interest.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Matsuzaki S, Pouly JL, Canis M, et al. Persistent activation of signal transducer and activator of transcription 3 via interleukin-6 trans-signaling is involved in fibrosis of endometriosis. Hum Reprod. 2022. PMID: 35551394. doi:10.1093/humrep/deac098

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。